Return on Investment | GenomeWeb

Return on Investment

While the US government invested a hefty sum — $14.5 billion between 1988 and 2012 — in the Human Genome Project, it has reaped $59 billion in tax revenue and $965 billion in economic impact, Bloomberg reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.